BACKGROUND Endometrial hyperplasia (EH) is a uterine pathology representing a
spectrum of morphological endometrial alterations. It is predominantly characterized by an …

Background The aim of this study was to summarize the global predicting role of hormone
receptors for survival in endometrial cancer. Methods Eligible studies were identified and …

STUDY QUESTION How should fertility-sparing treatment of patients with endometrial
carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were …

Endometrial cancer (EC) is the most frequent malignant tumor of the female genital tract.
Increasing evidence suggests that at least two different types of EC exist. Type I is …

Endometrial carcinoma is the most common invasive neoplasm of the female genital tract
and the fourth most frequently diagnosed cancer in the United States. In 1991 there were an …

Simple Summary Ovarian and endometrial cancers occur frequently and can be lethal.
Recently, progesterone receptor membrane component (PGRMC) 1 and PGRMC2 have …

Objective. The aim of this study was to evaluate the prognostic significance of steroid
hormone receptors in endometrial carcinoma using immunohistochemical staining for …

Objective In endometrial cancer loss of progesterone receptor (PR, gene name PGR) is
associated with aggressive disease and altered response to hormonal treatment. The aim of …

Estrogen and progesterone are important hormones secreted by the ovary acting through
specific receptors. Tumor tissue expression profiles of these have demonstrated prognostic …

Background: Endometrial cancer (EC) is a major gynecologic adenocarcinoma that arises
from the endometrium. While the incidence of EC is on the rise worldwide, survivorship and …